HDAC9 and cancer: It has been found to alter heterochromatin structure in murine embryonic cells, inhibit DNMTs in diverse human and animal cell lines, and induce demethylation in some cancers; meanwhile, it has acted as an HDAC inhibitor in other types of cancer [254,255,256].